Comment

Comment by suzie on July 27, 2013 at 7:03pm

Theses freeks love to roll there eyes and mock you in public, what kills me is the moron public that just laughs .. The questioner was polite and deserved an answer without the better than thou answer telling him he needed to go back to biology 101 in high school .. And of course he lied, I have watched the entire documentary its a good one and worth watching

Comment by Ria on July 27, 2013 at 6:43pm

[contd. from above.....................]

 

16. November 1989:The Chicago Tribune publishes John Crewdson's 50,000-word article on the discovery of HIV ("The Great AIDS Quest," Nov. 19, 1989), provoking new concerns about fraud and misconduct.

17. December 1989:Rep. John Dingell (D-Mich.), writes to NIH to inquire how it plans to investigate the charges made in Crewdson's article.

18. October 1990:NIH's Office of Scientific Integrity (OSI) begins a formal investigation of Gallo and Popovic regarding possible misconduct associated with a May 1984 Science paper.

19. June 1991:An OSI draft report finds Popovic guilty of scientific misconduct and states that Gallo's actions "warrant significant censure."

20. October 1991:The U.S. Attorney for the District of Columbia declines prosecution, citing insufficient evidence and complexity of the issues, and stating that alleged falsifications in the May 1984 paper are immaterial.

21. January 1992:A National Academy of Sciences-nominated panel chaired by Yale University biochemist Frederic Richards issues a report critical of Gallo. Its recommendations are not incorporated into the OSI report. The Dingell subcommittee on oversight and investigations begins its probe by serving NIH with a document request.

22. March/April 1992:The OSI final report is released with fewer charges against Popovic. The call for censure of Gallo is withdrawn.

23. June 1992:HHS commissions a Chicago law firm, Allegretti and Witcoff, to review the U.S. and French patent claims. The lawyers conclude that there is no evidence of falsification in the LTCB patent application and no intent by Gallo to act inequitably.

24. December 1992:The Office of Research Integrity (ORI) completes its review of the OSI report. ORI finds Gallo guilty of misconduct and reaffirms OSI's charges against Popovic.

25. August 1993:ORI issues a 99-page "Offer of Proof," listing numerous scientists willing to testify against Gallo.

26. November 1993:The Departmental Appeals Board exonerates Popovic of misconduct. Subsequently, ORI withdraws all charges against Gallo.

27. January 1994:The United States Attorney for the District of Maryland in Baltimore declines to prosecute Gallo and Popovic for allegedly making false statements on the patent application, citing statute of limitations and jurisdictional problems, among other concerns.

28. June 1994:The HHS Inspector General issues a 35-page closing memorandum on the Gallo case, documenting evidence against the LTCB scientist.

29. July 1994:NIH, now under director Harold Varmus, renegotiates the blood test royalty split with the French. The new agreement guarantees that the French will receive 50 percent of the royalties. Gallo will continue to receive $100,000 a year.

30. December 1994:The Dingell subcommittee report is leaked to the press just before the transition from Democratic to Republican control in the Congress. An article in the Chicago Tribune appears on Jan. 1, 1995 (J. Crewdson, section 1, page 1).

31. February 1995:Dingell writes a letter to Varmus saying he "cannot vouch for the authenticity" of the document bearing his subcommittee's name.

Comment by Ria on July 27, 2013 at 6:41pm

1. May 1983:Scientists at the Institut Pasteur (IP) publish a paper identifying a virus they call LAV that they have isolated from AIDS patients (F. Barre-Sinoussi et al., Science, 220:868-71, 1983). In the same issue, Robert Gallo and associates publish papers on the relationship between the leukemia virus HTLV-I and AIDS (E.P. Gelmann et al., Science, 220:862-5, 1983; R.C. Gallo et al., Science, 220:865-7, 1983).

2. July 1983:IP scientists send virus isolates to Gallo's Laboratory of Tumor Cell Biology (LTCB) at NIH.

3. September 1983:Additional samples of the French isolates are sent to LTCB. One of these is LAV/LAI, IP's prototype HIV isolate. A transfer agreement is included restricting commercialized applications of the French viruses.

4. November 1983:According to LTCB scientists, Mikulas Popovic starts his pool experiment from which the LTCB HIV isolate, HTLV-IIIb, is generated.

5. December 1983:IP scientists file for a U.S. patent for their LAV antibody blood test. According to the Dingell subcommittee report, between December and May, the application is assigned to three patent examiners, none of whom enters it into PTO's central records system.

6. January 1984:LTCB contractor M. Sarngadharan creates a virus antibody blood test.

7. March 1984:Gallo and associates submit four papers to Science describing discovery of the virus and development of a blood test.

8. April 1984:The Department of Health and Human Services (HHS) holds a press conference to announce the discovery of the virus and development of the blood test. The same day, Gallo and associates submit patent applications for the blood test and for the method of growing the virus.

9. May 1984:Four papers written by LTCB scientists are published in Science (M. Popovic et al., 224:497-500; J. Schupback et al., 224:503-5; R.C. Gallo et al., 224:505-6; M.G. Sarngadharan et al., 224:506-8).

10. May 1985:Gallo and his associates are awarded a U.S. patent on the HIV antibody blood test. The French application is still pending.

11. August 1985:French officials register a complaint with HHS, charging that HTLV-IIIb is LAV. They ask for equal share of credit and royalties. National Cancer Institute associate director Peter Fischinger investigates and rejects the French claims.

12. November-December 1985:Negotiations between HHS and IP attorneys break down. The French file suit in U.S. Court of Claims charging breach of contract.

13. April 1986:The U.S. Patent and Trademark Office declares an "interference" between the LTCB and IP applications, a process for judging the merits of competing claims.

14. March 1987:President Ronald Reagan and French Prime Minister Jacques Chirac agree on a settlement to end the patent dispute and divide the royalties. As a result of sales, the U.S. earns more money under the agreement.

15. April 1987:HIV geneticist Gerald Myers writes a memo to senior officials calling Gallo's statements that LAV and HTLV-IIIB are genetically independent and that HTLV-IIIb originated from a virus pool a "double fraud."

[contd. below......................../-]